ETrade Capital Management’s NeoGenomics NEO Stock Holding History

ETrade Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.65M	Buy	44,603 +955	+2%	+$35.5K	0.03%	249
2020 Q2	$1.35M	Buy	43,648 +628	+1%	+$17.4K	0.03%	278
2020 Q1	$1.19M	Buy	43,020 +3,315	+8%	+$99.3K	0.03%	262
2019 Q4	$1.16M	Buy	39,705 +1,279	+3%	+$30.5K	0.03%	322
2019 Q3	$735K	Buy	38,426 +4,334	+13%	+$102K	0.02%	435
2019 Q2	$748K	Buy	34,092 +6,148	+22%	+$135K	0.02%	423
2019 Q1	$572K	Buy	+27,944	New	+$486K	0.02%	487

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ETrade Capital Management's NEO Position: Q3 2020 in Review

ETrade Capital Management increased its NeoGenomics (NEO) stake by 2.2% in Q3 2020, buying an estimated $35.5K and bringing the position to 44,603 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #249.

ETrade Capital Management first reported a position in NEO in Q1 2019 and has held it in 7 quarters since. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

ETrade Capital Management held 44,603 shares of NeoGenomics worth $1.65M as of Q3 2020.
ETrade Capital Management bought 955 NeoGenomics shares in Q3 2020, an estimated $35.5K.
NeoGenomics made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #249 holding.
ETrade Capital Management first reported a position in NeoGenomics in Q1 2019 and has held it in 7 quarters since.
294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.